The high cost of second-line HIV drugs has increased Brazil’s AIDS med spending by 75% in the past two years, raising questions about the country’s ability to continue providing HIV treatment for free. Second-line meds are crucial for people with HIV who have built up drug resistance; Brazil, the first developing country to fund treatment, is among many beginning to face this second-line crisis.